Top Biopharmaceuticals Companies

The biopharmaceuticals market is undergoing significant transformation, driven by government initiatives and strategic investments worldwide. In the United States, the National Institutes of Health (NIH) allocated $48 billion in 2024 to support biomedical research, emphasizing the development of innovative therapies and personalized medicine. China's "Healthy China 2030" plan commits $1 trillion by 2030 to enhance healthcare infrastructure and biopharmaceutical innovation, positioning the country as a global biotech leader. India's Production Linked Incentive (PLI) Scheme for Pharmaceuticals, with a budget of $2 billion, aims to boost domestic manufacturing and reduce import dependence, fostering growth in high-value biopharmaceutical products. These government-backed strategies are reshaping the competitive landscape, promoting collaborations, and accelerating the development of advanced biologics and biosimilars globally.

Top Player’s Company Profiles in Biopharmaceuticals Market

• Pfizer Inc
• Roche Holding AG
• Johnson & Johnson (Janssen Biotech)
• Merck & Co. (MSD outside the U.S. and Canada)
• AbbVie, Inc.
• Sanofi
• Novartis AG
• Bristol-Myers Squibb
• AstraZeneca Plc
• Amgen, Inc.
• GSK (GlaxoSmithKline)
• Eli Lilly and Company
• Regeneron Pharmaceuticals
• Biogen
• Gilead Sciences
• Moderna
• Bayer AG
• CSL Limited
• Takeda Pharmaceutical Company
• Genmab